Ocriplasmin (Jetrea)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ocriplasmin (Jetrea), covering 2014-05-05 to 2014-05-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion [Phase 2]